98%
921
2 minutes
20
The present experiment assessed, in children aged 7-11 and in adults, whether postural control is affected by cognitive processes and vice versa. Using a dual-task, the level of difficulty of a Stroop task and bipedal quiet stance varied alternatively. We hypothesised that the interference between cognitive and postural tasks was non-linear during childhood with a so-called turning point around 8. Twenty-seven children 7- to 11-years-old and nine adults participated in the experiments. The postural task was executed in a semi-tandem Romberg position. Two cognitive conditions (congruent and non-congruent Stroop conditions) and two postural situations (with and without perturbed proprioceptive inputs) were presented simultaneously with the instruction to respond as correctly as possible while remaining as stable as possible. Results showed that, in the Vib condition, CoP mean velocity decreased with the increased cognitive complexity only in children aged 7. Moreover, the data showed a non-linear decrease in postural sway during childhood, whatever the level of complexity of the cognitive and/or postural tasks. CoP mean amplitude and mean velocity decreased between 7 and 8, and again between age 11 and adults. This study (1) confirmed that the interference between mental activity and postural control can be attributed mainly to attentional limitations, (2) showed the existence of a turning point around 8 in the development of this capacity, and (3) suggested that the mature level of attentional resources was not reached until age 11. Further research is needed to assess the development of attention implied in a cognitive/postural dual-task, including probably another so-called turning point during the adolescence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gaitpost.2010.07.008 | DOI Listing |
J Strength Cond Res
September 2025
Institute for Data Analysis and Process Design, ZHAW, Zurich, Switzerland; and.
Achermann, BB, Drewek, A, and Lorenzetti, SR. Acute effect of the bounce squat on ground reaction force at the turning point and barbell kinematics. J Strength Cond Res XX(X): 000-000, 2025-The free-weight back squat is a key exercise for developing lower-body strength, with variations that influence muscle activation and performance.
View Article and Find Full Text PDFJ Thorac Oncol
September 2025
Institut du Thorax Curie-Montsouris, Paris, France; Paris-Saclay University, UVSQ-Versailles, France.
Introduction: Amivantamab plus lazertinib significantly improved progression-free and overall survival versus osimertinib in patients with previously untreated, EGFR-mutant advanced NSCLC. EGFR-targeted therapies are associated with dermatologic adverse events (AEs), which can affect quality of life (QoL). COCOON was conducted to assess prophylactic management and improve treatment experience.
View Article and Find Full Text PDFJSLS
September 2025
Florida Surgical Specialists, Bradenton, Florida, USA. (Drs. Popover, Wallace, Feldman, Chastain, Kalathia, Imam, Almasri, and Toomey).
Objective: Artificial intelligence (AI) is a turning point in medical advancement. Despite the burgeoning research in this field, there exists a general lack of overview of where AI is being most utilized. This study reviews and describes techniques and trends of AI in the major medical specialties.
View Article and Find Full Text PDFPlatelets
December 2025
Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
The integrin family of extracellular matrix (ECM) adhesion receptors plays a central role in platelet function, including adhesion and aggregation. In resting platelets, integrins exist in a low-affinity state for their ligands, and are activated upon ligand binding to the extracellular domain or binding of cytoplasmic proteins such as talin to the intracellular β-tail. Talin function is regulated through autoinhibition, which reduces its integrin-activating function.
View Article and Find Full Text PDFESMO Open
September 2025
Sarah Cannon Research Institute United Kingdom, London, UK. Electronic address:
Background: Antibody-drug conjugates (ADCs) combine targeted monoclonal antibodies with cytotoxic payloads and are an emerging modality in systemic cancer therapy. Thirteen ADCs are Food and Drug Administration approved, with many more in development. However, design and use remain challenging, with issues including on/off-target toxicity, resistance from prior exposure to payload classes, and optimal target/payload selection.
View Article and Find Full Text PDF